Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Eyenovia stock | $4.02

Learn how to easily invest in Eyenovia stock.

Eyenovia Inc is a biotechnology business based in the US. Eyenovia shares (EYEN) are listed on the NASDAQ and all prices are listed in US Dollars. Eyenovia employs 31 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Eyenovia

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – EYEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Eyenovia stock price (NASDAQ: EYEN)

Use our graph to track the performance of EYEN stocks over time.

Eyenovia shares at a glance

Information last updated 2021-10-24.
Latest market close$4.02
52-week range$3.16 - $7.72
50-day moving average $5.15
200-day moving average $4.95
Wall St. target price$15.67
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.79

Buy Eyenovia shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Eyenovia stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Eyenovia price performance over time

Historical closes compared with the close of $4.02 from 2021-10-25

1 week (2021-10-20) -30.45%
1 month (2021-09-27) -19.44%
3 months (2021-07-27) -7.16%
6 months (2021-04-27) -26.37%
1 year (2020-10-26) 15.85%
2 years (2019-10-25) 22.56%
3 years (2018-10-26) 6.63%
5 years (2016-10-23) N/A

Eyenovia financials

Revenue TTM $6 million
Gross profit TTM $1.2 million
Return on assets TTM -57.75%
Return on equity TTM -225.26%
Profit margin 0%
Book value $0.35
Market capitalisation $170.7 million

TTM: trailing 12 months

Shorting Eyenovia shares

There are currently 183,528 Eyenovia shares held short by investors – that's known as Eyenovia's "short interest". This figure is 25.1% up from 146,711 last month.

There are a few different ways that this level of interest in shorting Eyenovia shares can be evaluated.

Eyenovia's "short interest ratio" (SIR)

Eyenovia's "short interest ratio" (SIR) is the quantity of Eyenovia shares currently shorted divided by the average quantity of Eyenovia shares traded daily (recently around 166843.63636364). Eyenovia's SIR currently stands at 1.1. In other words for every 100,000 Eyenovia shares traded daily on the market, roughly 1100 shares are currently held short.

However Eyenovia's short interest can also be evaluated against the total number of Eyenovia shares, or, against the total number of tradable Eyenovia shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Eyenovia's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Eyenovia shares in existence, roughly 10 shares are currently held short) or 0.0102% of the tradable shares (for every 100,000 tradable Eyenovia shares, roughly 10 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Eyenovia.

Find out more about how you can short Eyenovia stock.

Eyenovia share dividends

We're not expecting Eyenovia to pay a dividend over the next 12 months.

Eyenovia share price volatility

Over the last 12 months, Eyenovia's shares have ranged in value from as little as $3.16 up to $7.72. A popular way to gauge a stock's volatility is its "beta".

EYEN.US volatility(beta: 2.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Eyenovia's is 2.1822. This would suggest that Eyenovia's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Eyenovia overview

Eyenovia, Inc. , a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its pipelines focus on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates in pipeline include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc.

Frequently asked questions

What percentage of Eyenovia is owned by insiders or institutions?
Currently 36.235% of Eyenovia shares are held by insiders and 10.062% by institutions.
How many people work for Eyenovia?
Latest data suggests 31 work at Eyenovia.
When does the fiscal year end for Eyenovia?
Eyenovia's fiscal year ends in December.
Where is Eyenovia based?
Eyenovia's address is: 295 Madison Avenue, New York, NY, United States, 10017
What is Eyenovia's ISIN number?
Eyenovia's international securities identification number is: US30234E1047
What is Eyenovia's CUSIP number?
Eyenovia's Committee on Uniform Securities Identification Procedures number is: 30234E104

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site